4.6 Review

The RGM/DRAGON family of BMP co-receptors

Journal

CYTOKINE & GROWTH FACTOR REVIEWS
Volume 20, Issue 5-6, Pages 389-398

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2009.10.008

Keywords

BMP; Receptors; RGM; DRAGON; HJV

Funding

  1. Massachusetts Biomedical Research Council
  2. MGH Executive Committee on Research
  3. Associazione Modenese per le Malattie del Fegato
  4. National Institutes of Health [K08 DK-075846, RO1 DK-069533, RO1 DK-071837]
  5. National Kidney Foundation
  6. Massachusetts General Hospital
  7. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071837, K08DK075846, R01DK069533] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The BMP signaling pathway controls a number of cell processes during development and in adult tissues. At the cellular level, ligands of the BMP family act by binding a hetero-tetrameric signaling complex, composed of two type I and two type If receptors. BMP ligands make use of a limited number of receptors, which in turn activate a common signal transduction cascade at the intracellular level. A complex regulatory network is required in order to activate the signaling cascade at proper times and locations, and to generate specific downstream effects in the appropriate cellular context. One such regulatory mechanism is the repulsive guidance molecule (RGM) family of BMP co-receptors. This article reviews the current knowledge regarding the structure, regulation, and function of RGMs, focusing on known and potential roles of RGMs in physiology and pathophysiology. (C) 2009 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available